19th Nationwide survey n; % | First cohort group n; % | p-value | Odds ratio | 95% CI | |
---|---|---|---|---|---|
Total | 20,475; 100.0 | 126; 100 | (crude) | ||
Initial IVIG therapy | 17,613; 86.0 | 101; 80.2 | 0.06 | 0.91 | 0.53–1.57 |
0.38* | 1.07* | 0.88 – 1.30* | |||
Acute phase CAL | 2,446; 11.9 | 6; 4.8 | < 0.01 | 2.71 | 1.19– 6.17 |
Cardiac sequelae | 772; 3.8 | 0; 0 | < 0.05 | 0 | ‡NA |
Additional IVIG therapy | 2,860; 14.0 | 9; 7.1 | 0.03 | 2.08 | 1.06–4.13 |